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Abstract
Objectives
To determine whether bronchial colonisations/infections with periodontopathogenic bacte-
ria are associated with elevated inflammatory markers such as MMPs, interleukins and
Tumor necrosis factor alpha in the bronchial fluid.
Methods
Periodontal status was assessed in consecutive outpatients planned for elective bronchos-
copies, and PCR for periodontopathogenic bacteria was performed from a protected speci-
men brush sample taken from the bronchial mucosa. Additionally, MMPs, interleukins and
Tumor necrosis factor alpha were measured in the bronchial fluid.
Results
Out of the four species assessed, one species was found in 13 of 91 (14%) patients, and
two in 12 (13%), three in 13 (14%) and all four in 1 (1%) patient, respectively. In multiple lin-
ear regression models the presence of Treponema denticola showed a consistent pattern
of positive effects in bronchial fluid (Bonferroni adjusted p-values) on the levels of MMP9 (p
adj.: 0.028) and MMP12 (p adj.: 0.029). Active smoking was independently associated with
increased levels of aMMP8 (p adj.: 0.005) and MMP9 (p adj.: 0.009). Levels of IL-1 ß, IL-8
and Tumor necrosis factor alpha measured in the bronchial fluid were not affected by the
presence of periodontopathogenic bacteria.
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Conclusions
Bronchial colonisation/infection with Treponema denticola and smoking are independently
associated with elevated MMPs (MMP9/MMP12 and MMP8/MMP9, respectively) in the
bronchial fluid.
Introduction
Periodontitis is a destructive inflammatory disease of the tooth-supportive tissues, including
alveolar bone and gingiva. Bone resorption and tissue destruction are thought to be the result
of the imbalance between bacterial colonisation and pathogenic inflammatory host response
[1]. Aggregatibacter actinomycetemcomitans (Aa), Porphyromonas gingivalis (Pg), Tannerella
forsythia (Tf) and Treponema denticola (Td) are considered to be the key pathogenic marker
species [2] and are classified together as the red complex in Socransky’s subgingival cluster
model [3].
Matrix metalloproteinases (MMPs) represent a group of structurally similar enzymes that
play a central role in inflammation related tissue degradation. In particular MMP8 and MMP9
in gingival fluid have been shown to be associated with periodontitis [4–6]. Furthermore, recent
studies showed elevated MMPs in bronchoalveolar lavage fluid in bacterial pneumonia [7] and
experimental lung injury [8,9]. MMPs and local levels of inflammatory mediators such as Inter-
leukin 1beta (IL1-ß), Interleukin 8 (IL-8) and Tumor necrosis factor alpha (TNF-α) were also
found to be elevated in periodontitis [10,11] as well as in infectious lung diseases [12].
The lower respiratory tract (LRT) is no longer believed to be sterile, mainly as a result of cul-
ture independent techniques, and its’ microbiome became a focus in healthy [13] and diseased
lung research [14–16]. In spite of the close anatomical proximity of the oral and bronchial
compartments, to date only few studies have addressed the colonisation of the lung with peri-
odontal pathogens. In a recent pilot study this research group was able to find key pathogenic
marker species in the lungs of lung transplant recipients despite the frequent use of antibiotics
in this population [17]. Recently, we have also shown in a larger population that periodontal
key pathogenic marker species can be frequently detected in the bronchial compartment [18].
It appears, therefore, that the oral and the bronchial compartment share some colonisation pat-
terns, particularly with regard to specific pathogenic key marker species. The preliminary and
semi-quantitative data found in this study also demonstrated that bronchial colonisation/infec-
tion with these species seemed to be associated with increased aMMP8 levels (semi-quantita-
tively assessed) in the bronchial fluid. Furthermore, periodontitis appeared to represent an
independent risk factor for bronchial colonisation/infection with the pathogenic marker spe-
cies of the red complex mentioned earlier [18].
Therefore the aim of the current study was to test the hypothesis that comparably to gingival
structures of the oral cavity, colonisation/infection in the lung with key pathogenic marker spe-
cies is also associated with increased levels of MMPs and other inflammatory markers, i.e. cyto-
kines, such as IL1-ß, IL-8 and TNF-α. In addition, assessment was made as to whether
periodontitis was associated with increased levels of the aforementioned markers.
Materials and Methods
Outpatients between 18 and 80 years of age, scheduled for elective bronchoscopy in Cantonal
Hospital, Aarau, were included in the current prospective study once their written informed
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consent was obtained. Exclusion criteria included the use of systemic or local antibiotics during
the preceding six weeks, less than four teeth or severe coagulopathy. In all patients, the entire
range of clinical information was available, as well as a body plethysmography (MasterScreen,
Jaeger, Hoechberg, Germany), which had been performed under stable clinical conditions
within one month prior to bronchoscopy. The study protocol was approved by the Ethics
Committee of the Canton Aargau, Switzerland (EK 2012/018).
The periodontal status assessment, the bronchoscopy procedure and the bronchial sample
collection have been described in detail previously [18]. In brief, a periodontal screening index
(PSI) was determined with the aid of a pressure-sensitive probe (Hawe Click Probe, Kerr
Hawe, Bioggio, Switzerland) [19]. Scores 0 to 4 were defined by assessment of probing pocket
depth and bleeding, (where scores 0, 1 and 2 infer no periodontits, and scores 3 and 4 infer
periodontitis) [20]. Trans-nasal bronchoscopy was carried out under sedation with propofol
(Disoprivan, Astra Zeneca, Zug, Switzerland) and local anesthesia of the vocal cords with 10 ml
of 1% lidocaine. The endoscope was placed directly into the middle lobe bronchus (or upper
lobe bronchus), without suction, and with the aid of a wax-plug protected specimen brush
(PSB) (Vygon, Niederwangen, Switzerland) the mucosa was sampled using a standardised
technique. Furthermore, 8 ml of physiologic saline was instilled into the lingua bronchus (or
upper lobe bronchus) and subsequently re-aspirated. The aspirate was frozen at -80°C and
referred for the measurement of inflammatory markers. Finally, another 8ml of physiologic
saline was instilled and the aspirate was then referred for conventional microbiology. Immedi-
ately after the procedure the PSB was placed in a transport vial and the bronchial fluid was fro-
zen at -80°C. In five patients sham PSB samples were taken in addition to the described
procedure (i.e. a complete procedure with PSB sampling but without mucosa contact of the
brush).
Using a commercially available PCR test (micro-IDent test, Hain Lifescience, Nehren, Ger-
many) [21] four key pathogenic marker species (Aa, Pg, Tf and Td) were determined in the
PSB sample (for details see [18]). In contrast to the original test, which applies semi-quantita-
tive results, increased cycles numbers of were used. Therefore, the results can be considered as
qualitative rather than quantitative.
Measurement of MMP-2 and MMP-12 was employed as being representative of biomarkers
of tissue damage, which have been investigated in lung diseases, to a certain degree [8,22,23].
MMP9 and MMP8 were chosen, since they are intensively investigated in periodontal research,
in particular MMP8 in its activated form. MMP-2, MMP-9 and MMP-12 levels were measured
using a multiplexed particle-based flow cytometric cytokine assay (Luminex Performance
Assay Human MMP, R&D Systems, USA) [24]. MMP2 and MMP9 (both detect pro- and
mature MMP forms; #LMP902C and #LMP911B); MMP12 (detect pro-, mature, and TIMP1
complexed MMP12; #LMP919B). The procedures closely followed the manufacturer’s instruc-
tions. The analysis was conducted using a conventional flow cytometer (Guava EasyCyte Plus,
Millipore, Zug, Switzerland).
The serum was assayed according to the manufacturer’s instructions using a commercially
available quantitative enzyme-linked immunosorbent assay (ELISA) for aMMP8 (Dentognos-
tics, Matrix Biotech, Jena, Germany) and Interleukin 1beta (IL1-ß), Interleukin 8 (IL-8) and
Tumor necrosis factor alpha (TNF-α) (Life technologies, Termo FischerScientific, Waltham,
MA, USA). Assays were performed in duplicate, and the optical density at 450nm was deter-
mined, with background correction 570nm, using a microplate reader (Labsystems iEMS
Reader MF). The reading for each standard and sample was averaged and the zero standard
average was subtracted. The lower limits of detection were as follows: aMMP8, 6pg/ml; IL1-ß,
2pg/ml; IL-8, 1pg/ml; TNF-α, 3pg/ml.
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Statistica software (release 10, StatSoft Inc., Tulsa, USA) and R programming language (R
Core Team (2012). R: A language and environment for statistical computing. R Foundation for
Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0) were used for statistical analyses.
Categorical data are presented as absolute numbers (percentages), continuous data as median
(interquartile range (IQR)). The non-parametric MannWhitney U test and chi-square test
were used to compare groups, where appropriate. In accordance with the research hypothesis,
multiple linear regression models were used to test the effects of the presence of the three key
pathogenic marker species (Pg, Tf and Td) assessed in the PSB sample (absence/presence: see
methods), periodontitis (absence/presence of PSI> 2: see methods) and active smoking
(absence/presence) on the level of the MMPs determined in the bronchial fluid. As a conse-
quence of too few events, Aa was not included in the model. One model was used for each of
the four MMPs (MMP2, aMMP8, MMP9 and MMP12) and p-values were correspondingly
adjusted for multiple testing (Bonferroni). Continuous response variables were either natural
Log or box-cox (power transformation yλ) transformed in order to reach appropriately distrib-
uted residuals. Active smoking was included in the model since elevated MMPs have been
shown in the periodontal tissue of smokers [25].
Results
Fig 1 shows the enrolment of the participant patients. All bronchoscopies were performed
without complication. The demographic and clinical data of the study population at baseline
are summarised and compared separately for patients with and without Td in Table 1 (the
grouping was chosen due to the impact of Td on MMPs mentioned later in the manuscript). In
the 91 patients, the PCR of the PSB lung sample for Aa, Pg, Tf and Td was positive in 4 (4%),
28 (31%), 27 (30%) and 21 (23%), respectively. In 13 (14%) patients one of the four species was
found, in 12 (13%) two species, in 13 (14%) three species and in 1 (1%) four species. PCR of all
five PSB sham samples was negative for all of the four key pathogenic marker species.
In 32 participants (35%), the following potentially pathogenic bacteria were found in the
bronchial fluid conventional cultures:Haemophilus influenza 12 (13%), Haemophilus parain-
fluenzae 14 (15%), Klebsiella pneumonia 2 (2%), Escherichia coli 1 (1%), Staphylococcus aureus
3 (3%), Pseudomonas aeruginosa 1 (1%), Streptococcus pneumonia 1 (1%) and Serratia marces-
cens 1 (1%). These microorganisms were not considered clinically relevant in any of the
patients.
The results of the bronchial fluid immunoassays for MMPs and interleukins in the overall
population investigated were as follows (Median, (IQR)): MMP2 639 (309–2215) pg/ml,
aMMP8 215 (91–492) ng/ml, MMP9 105.6 (52–265.8) ng/ml, MMP12 5 (5–20.7) pg/ml, IL1ß
15.3 (13.5–16.7) pg/ml, IL8 10.4 (8.3–11.8) pg/ml and TNF-α 16.5 (13.8–20.5) pg/ml.
The results of the multiple linear regression models testing the effects of the three key patho-
genic marker species (Pg, Tf and Td), the presence or absence of periodontitis and the presence
or absence of active smoking on the four MMPs are given in Table 2. Models including Aa lead
to absolutely equivalent results, however, due to infrequent events, it was decided to exclude it
from the final models. Among the three pathogenic markers, Td shows a consistent positive
effect pattern regarding the levels of the four MMPs (Fig 2). Interaction terms were non-signifi-
cant and therefore were excluded from the models. The same models were applied to test the
effects on IL1-ß, IL-8 and TNF-α, however, a statistically significant effect of active smoking
was shown only in case of IL1-ß (p = 0.009, results not numerically shown, see Fig 3). Further,
we included COPD or the presence of potentially pathogenic bacteria found in the conven-
tional culture, as a covariate in these models. However, neither affected MMPs, cytokines or
any of the results mentioned above (data not shown).
Bronchial Infection with Periodontopathogens
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Discussion
Lung microbiome has gained interest in the literature, in particularly, it has been recognised
that even in asymptomatic patients, lung microbiome does not merely reflect the bacterial
composition of the upper airways [26]. Recently we have shown in a relatively large population
that periodontal pathogenic species can be frequently detected in bronchi [18]. Therefore, the
current observational study investigated the hypothesis that a bronchial colonisation with the
four key pathogenic marker species Aa, Pg, Tf and Td is associated with similar local inflamma-
tory reactions as observed in affected periodontal sites.
MMPs seem to represent important peptides and markers in both, the pathogenesis of lung
diseases [7,9,27,28] and periodontitis [5,25,29]. Therefore, in the current study MMP2,
aMMP8, MMP9 and MMP12 were measured in the bronchial fluid of 91 patients undergoing
Fig 1. Enrolment of study participants.
doi:10.1371/journal.pone.0144461.g001
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elective diagnostic bronchoscopy and these findings correlated with the presence of perio-
pathogenic marker species. Several of our observations were remarkable as expected.
Firstly, we found that the presence of Td in the bronchial compartment was associated with
increased levels of MMPs, particularly aMMP8 and MMP9. This is in agreement with recent
studies [4,30,31], which measured increased MMPs in the gingival crevicular fluid of patients
with infected periodontal tissues. In addition to the four key pathogenic marker species Aa, Pg,
Tf and Td Yakob et al. [4] also performed PCR in gingival fluid for Prevotella intermedia. The
authors found that increased levels of MMP8 in the gingival crevicular fluid were associated
with the presence of Tf and Td whereas increased MMP9 was exclusively associated with Td.
This was corroborated by the present study, which also found significantly increased levels of
MMP9 in the bronchial fluids, which were strongly associated with the presence of Td. In con-
trast, for Tf no significant association was found. This may be partly the consequence of the
fact, that the activated form of MMP8 was measured in this study. In the case of periodontitis
the interaction of Td and oral host proteins has been studied many times, and extensively
reviewed [32]. It seems that bronchial colonisation/infection with Td is associated with local
pro-inflammatory processes in comparable ways. Although increased levels of MMP8 and
MMP9 of bronchoalveolar lavage fluid in earlier studies have been associated with severe infec-
tious conditions such as ventilator associated pneumonias [7,33],the exact role of MMPs in
inflammatory diseases of the lung is not yet understood. Data concerning levels of MMPs and
development or progression of COPD for example, are conflicting [27,34]. Cell surface lipo-
polysaccharides of Td that bind to extracellular matrix components of the periodontal tissue
seem to induce pro-inflammatory pathways, which eventually contribute to the development
Table 1. Demographic and clinical data of the study population.
Td bronchial—(n = 70) Td bronchial + (n = 21)
Characteristic p
Age, years 60 (48 to 71) 59 (48 to 64) 0.581
Gender, female 23 (33) 6 (29) 0.711
Smoking status
Current smoker 25 (36) 4 (19) 0.151
Former smoker 22 (31) 6 (29) 0.803
Never smoker 23 (33) 11 (52) 0.105
COPD 15 (21) 6 (29) 0.495
Gold I 3 (4) 4 (19)
Gold II 9 (13) 1 (5)
Gold III 2 (3) 1 (5)
Gold IV 1 (1) 0 (0)
Lung cancer, yes 23 (33) 5 (24) 0.431
Periodontal status
PSI 0 23 (33) 4 (19) 0.224
PSI 1–2 36 (51) 8 (38) 0.283
PSI 3–4 11 (16) 9 (43) 0.008
Td:Treponema denticola, COPD:chronic obstructive pulmonary disease (Classiﬁcation according to the degree of airﬂow limitation I to IV: forced volumen
in one second 80% predicted, 50–80% predicted, 30–50% predicted and <30% predicted, respectively), PSI = periodontal screening index
(Classiﬁcation according to the probing pocket depth and bleeding 0 to 4: scores 0, 1 and 2: no periodontitis, scores 3 and 4: periodontitis)
Data presented as median (IQR) or number (%), Mann-Whitney U and Chi-square test were used where appropriate
doi:10.1371/journal.pone.0144461.t001
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of periodontitis [35]. In the current study evidence was found that Td is associated with ele-
vated MMPs in the bronchial compartment. However, whether comparable inflammatory
mechanisms underlie in the periodont and in the bronchial compartment, respectively, needs
to be investigated in future studies. So far, beside. . . (hier muss noch MMP2, MMP12 in der
Lunge erörter warden; MMP9 und 8 ist oben erwähnt).
Secondly, smokers have shown increased levels of aMMP8 and MMP9 in the bronchial
fluid independently of the presence of Td. This finding shows similarities with recent observa-
tions reported by Victor and co-workers [25]. In the latter study, MMP8 and MMP9 were
determined in the gingival crevicular fluid of smokers and non-smokers suffering from chronic
periodontitis. Smoking and periodontitis were both associated with increased levels of MMP8
and MMP9 in gingival crevicular fluid in the sense of additional factors. Increased levels of
MMP8 and MMP9 in the bronchoalveolar lavage fluid of smokers [34] and induced sputum of
smokers [23], respectively, have been reported earlier. However, to our knowledge, the current
study was the first to demonstrate that smoking and the presence of Td in the bronchial com-
partment are independently associated with increased levels of aMMP8 and MMP9 in an addi-
tional sense.
Interestingly, in the case of the cytokines IL1- ß, TNF-α and IL-8, consistent patterns could
not be found. Noh et al. [11] found increased IL8 and TNF alpha levels in gingival tissue of
patients suffering from periodontitis. Although, IL1-ß,and IL-8 have been found to be elevated
Table 2. Multiple linear regression models with the response variable given by the level of matrix metalloproteinases in bronchial fluid. Given are
the coefficient of multiple determination (R2), estimates, standard error, the corresponding p-values and the corresponding p-values adjusted for multiple test-
ing (Bonferroni). Signicant p-values are indicated in bold font (i.e. < 0.05).
Response variable R2 predictors Estimate Std. Error p adj. P
MMP2 0.114 Pg+ bronchial -0.603 0.346 0.085 0.340
Tf+ bronchial 0.122 0.364 0.737 1.000
Td+ bronchial 0.988 0.408 0.018 0.071
Periodontits (PSI>2) 0.119 0.344 0.730 1.000
Active smoking 0.485 0.293 0.102 0.407
aMMP8 0.180 Pg+ bronchial -0.089 0.203 0.664 1.000
Tf+ bronchial -0.011 0.213 0.957 1.000
Td+ bronchial 0.593 0.240 0.016 0.062
Periodontits (PSI>2) 0.066 0.203 0.746 1.000
Active smoking 0.573 0.171 0.001 0.005
MMP9 0.203 Pg+ bronchial -0.009 0.644 0.989 1.000
Tf+ bronchial 0.090 0.677 0.895 1.000
Td+ bronchial 2.103 0.760 0.007 0.028
Periodontits (PSI>2) 0.300 0.640 0.640 1.000
Active smoking 1.711 0.546 0.002 0.009
MMP12 0.149 Pg+ bronchial -0.028 0.273 0.919 1.000
Tf+ bronchial -0.285 0.287 0.323 1.000
Td+ bronchial 0.886 0.322 0.007 0.029
Periodontits (PSI>2) 0.130 0.271 0.632 1.000
Active smoking 0.569 0.231 0.016 0.063
MMP:matrix metalloproteinase, Pg: Porphyromonas gingivalis, Tf: Tannerella forsythia, Td:Treponema denticola, coded yes/no (see methods),
PSI = periodontal screening index (Classiﬁcation according to the probing pocket depth and bleeding 0 to 4: scores 0, 1 and 2: no periodontitis, scores 3
and 4: periodontitis).
doi:10.1371/journal.pone.0144461.t002
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in the bronchoalveolar lavage fluid of patients suffering from ventilator associated pneumonias
[12], it appears that in contrast to MMPs the levels of these cytokines in the bronchial fluid are
not consistently altered in the case of smoking or colonisation/infection with periopathogens.
This may be the consequence of a more discrete inflammation in the latter cases. Furthermore,
Fig 2. Levels of matrix metalloproteinases in the bronchial fluid of patients, with and without bronchial colonisation with Treponema denticola
(Td), shown separately for active smokers (dark grey) and non-smokers (transparent). The y-axes are either ln- or box-cox-transformed, corresponding
to the transformations used in the multiple regression models. The dots indicate outliers.
doi:10.1371/journal.pone.0144461.g002
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it was likely that cytokines secreted in focal areas of inflammation in the lungs were degraded
locally or removed in the circulation before they diffused into the bronchial fluid.
Somewhat surprisingly and apparently in contrast to other authors [23,27,34] we could not
correlate the levels of MMPs measured in bronchial fluid with the presence or absence of
COPD. However, taking a closer look in one study [27], no information was provided
Fig 3. Cytokine levels in the bronchial fluid of patients with and without bronchial colonisation with Treponema denticola (Td), shown separately
for active smokers (dark grey) and non-smokers (transparent). The y-axes are box-cox-transformed, corresponding to the transformations used in the
multiple regression models. The dots indicate outliers.
doi:10.1371/journal.pone.0144461.g003
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regarding the smoking status of the study participants. In another study [23], which investi-
gated the levels of MMP8, MMP9 and MMP12 in the induced sputum, only MMP8 was higher
in symptomatic smokers with COPD Stage GOLD 0 compared to non-symptomatic smokers.
In this study no information is available concerning activated MMP8. Finally, D’Armiento
et al. [34] found significantly elevated MMP9 in bronchoalveolar lavage fluid in both smokers
and former smokers with emphysema compared to non-smoking controls. However, MMP9
neither correlated with the severity of COPD nor with the degree of disease progression over
an 18- month period. Although the role of MMPs and its’ polymorphisms for the development
of COPD are discussed extensively in the literature (summarised in [28]), the exact part of
MMPs in COPD pathogenesis is not well characterised as yet.
In an earlier study [18] this research group demonstrated that periodontitis appeared to be
a risk factor for bronchial colonisation/infection with periopathogens. Therefore, the group
expected its current analysis to show that patients suffering from periodontitis might also be
more vulnerable to pro-inflammatory consequences of colonisation/infection with periopatho-
gens in the bronchial compartment. However, no evidence was found to support this hypothe-
sis. This may be consequent on having information about the earlier treatment of periodontitis
in the participant population, and potentially this interacted with the presence or absence of
periodontitis at the time of the study investigation.
The current study is subject to some limitations. Although, to the best of our knowledge
so far no data exist concerning inflammatory consequences of bronchial colonisation/infec-
tion with periopathogens based on our data we are not able to characterise the clinical impli-
cations of these findings in our population. This outcome may be the consequence of the
relatively small number of patients and their heterogeneity. In addition, the relatively limited
scientific data available concerning the role of MMPs in lung disease and the cross sectional
design of the current study hinder the clinical interpretation of our results Due to the rela-
tively small number of patients the impact of potential additional factors on the levels of
inflammatory markers could not be analysed in the regression models employed. Another
shortcoming is the fact, that tissue inhibitors of metalloproteases were not measured in the
current study. Furthermore, although evidence was found for local inflammatory reactions in
the case of Td, these researchers could not differentiate between detection, colonisation and
infection.
In summary, this cross sectional study has shown that smoking and bronchial colonisation/
infection with Td are independently associated with elevated MMPs (aMMP8/MMP9 and
MMP9/MMP12, respectively) in the bronchial fluid in a relatively large population.
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